A Drug Utilization Study to Evaluate the Effectiveness of Risk Minimization Measures (RMMs) for Abrocitinib in the EU Using Electronic Healthcare Data (B7451085)

29/11/2024
07/01/2025
EU PAS number:
EUPAS1000000345
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

B7451085_ABROCITINIB PROTOCOL AMENDMENT 1_23MAY2024.pdf

English (590.14 KB - PDF) View document
Study results
Study report
Other information